-
FDA Fellowship in Generic Opioid Bioequivalence and Safety Research
U.S. Food and Drug Administration (FDA)
-
FDA Fellowship – Systematic Evaluation of Factors Affecting Disease Progression, Pharmacodynamics and Treatment Response in Neurodegenerative Conditions
U.S. Food and Drug Administration (FDA)
-
FDA Nonclinical Neural NAMs Fellowship
U.S. Food and Drug Administration (FDA)
-
Research Scientist
California Department of Public Health (CDPH)
-
Bakersfield, CA
California Department of Public Health (CDPH)
-
Building Maintenance Worker
California Department of Public Health (CDPH)
-
Program Analyst
California Department of Public Health (CDPH)
-
Attorney III
California Department of Public Health (CDPH)
-
Electrician II
California Department of Public Health (CDPH)
-
Licensing Analyst
California Department of Public Health (CDPH)
-
Nurse Surveyor Supervisor
California Department of Public Health (CDPH)
-
Vital Records Request Processing Technician
California Department of Public Health (CDPH)
-
Nurse Surveyor
California Department of Public Health (CDPH)
-
CDC Paula E. Jayne Fellowship for Adolescent & School Health
Centers for Disease Control and Prevention (CDC)
-
CDC Training Fellowship in Molecular Pathology for Pathogen Diagnostics and Discovery
Centers for Disease Control and Prevention (CDC)
-
Local Contract Analyst
California Department of Public Health (CDPH)
CPH Preferred -
Vital Records Technician
California Department of Public Health (CDPH)
-
District Administrator
California Department of Public Health (CDPH)
-
System Admin Specialist
California Department of Public Health (CDPH)
-
Section Chief
California Department of Public Health (CDPH)
-
Procurement Analyst
California Department of Public Health (CDPH)
-
Payroll Special Projects Analyst
California Department of Public Health (CDPH)
-
Regional Disaster Public Health Representative
California Department of Public Health (CDPH)
Anywhere -
Payroll and Benefit Services Unit Chief
California Department of Public Health (CDPH)
Anywhere -
FDA Determination of Qualification Limits for Peptide-related Impurities of Follow-on Products to Inform Guidance
U.S. Food and Drug Administration (FDA)